In December 2015 the Medical Technologies Evaluation Programme was considering the need to review this guidance. To register as a stakeholder please contact us at

NICE has developed medical technology guidance on the geko device.

NICE medical technologies guidance addresses specific technologies notified to NICE by manufacturers. The ‘case for adoption’ recommendations are based on the claimed advantages of introducing the specific technology compared with current management of the condition. This ‘case’ is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.

NICE has said that the geko device can be used for people in whom it is not possible to use other methods of preventing blood clots.

  • National Institute for Health and Care Excellence (NICE) accreditation logo